Growth Metrics

Merck (MRK) Non-Current Assets (2016 - 2026)

Merck has reported Non-Current Assets over the past 18 years, most recently at $125.0 million for Q1 2026.

  • Quarterly Non-Current Assets fell 99.84% to $125.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $125.0 million through Mar 2026, down 99.96% year-over-year, with the annual reading at $125.0 million for FY2025, N/A changed from the prior year.
  • Non-Current Assets was $125.0 million for Q1 2026 at Merck, roughly flat from $125.0 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $82.0 billion in Q3 2025 and troughed at $125.0 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $74.5 billion (2023), against an average of $66.5 billion.
  • Year-over-year, Non-Current Assets rose 20.89% in 2022 and then crashed 99.84% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $73.4 billion in 2022, then grew by 1.46% to $74.5 billion in 2023, then increased by 3.58% to $77.2 billion in 2024, then tumbled by 99.84% to $125.0 million in 2025, then changed by 0.0% to $125.0 million in 2026.
  • Per Business Quant, the three most recent readings for MRK's Non-Current Assets are $125.0 million (Q1 2026), $125.0 million (Q4 2025), and $82.0 billion (Q3 2025).